Jean-Jacques Bienaimé
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Keros Therapeutics, Inc. (KROS)
SEC 8-K
Current2024-07-01–present
-
Current
2024-06-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Recent activity
No earnings-call appearances or filed executive changes recorded yet.